302 results on '"Rostron, Brian"'
Search Results
2. The contribution of smoking-attributable mortality to differences in mortality and life expectancy among US African-American and white adults, 2000–2019
3. Assessing the relationship between biomarkers of exposure and biomarkers of potential harm: PATH Study Wave 1 (2013-2014)
4. Correction to: Modeling mortality risk effects of cigarettes and smokeless tobacco: results from the national health interview survey linked mortality file data
5. Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014).
6. Assessing quality-adjusted years of life lost associated with exclusive cigarette smoking and smokeless tobacco use
7. US Adult Cigar Smoking Patterns, Purchasing Behaviors, and Reasons for Use According to Cigar Type : Findings From the Population Assessment of Tobacco and Health (PATH) Study, 2013–2014
8. Modeling mortality risk effects of cigarettes and smokeless tobacco: results from the National Health Interview Survey Linked Mortality File Data
9. Cigar smoking prevalence and morbidity among US adults, 2000–2015
10. Supplemental Table 4 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
11. Supplemental Table 6 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
12. Supplemental Table 5 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
13. Supplemental Table 3 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
14. Supplemental Table 2 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
15. Supplemental Figure 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
16. Supplemental Table 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
17. Data from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
18. Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
19. Notes from the Field: E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022–March 31, 2023
20. Burn injuries related to E-cigarettes reported to poison control centers in the United States, 2010–2019
21. Electronic nicotine delivery system (ENDS) liquid nicotine exposure in young children presenting to US emergency departments, 2018
22. Annual U.S. Healthcare Spending Attributable to Cigar Smoking between 2001 and 2018
23. Characteristics and Patterns of Cigarette Smoking and Vaping By Past-Year Smokers Who Reported Using Electronic Nicotine Delivery System to Help Quit Smoking in the Past Year: Findings From the 2018–2019 Tobacco Use Supplement to the Current Population Survey
24. Electronic cigarette use among US adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013–2014
25. Mortality Risks Associated With Environmental Tobacco Smoke Exposure in the United States
26. Electronic nicotine delivery system (ENDS) battery-related burns presenting to US emergency departments, 2016
27. NNAL Exposure by Race and Menthol Cigarette Use among U.S. Smokers
28. Methodology, Menthol, and Mortality
29. Smoking-Attributable Mortality by Cause in the United States : Revising the CDC’s Data and Estimates
30. Additional file 1 of Correction to: Modeling mortality risk effects of cigarettes and smokeless tobacco: results from the national health interview survey linked mortality file data
31. Response to “Menthol Cigarettes and Lung Cancer Mortality”
32. Lung Cancer Mortality Risk for U.S. Menthol Cigarette Smokers
33. Patterns of Use of Smokeless Tobacco in US Adults, 2013-2014
34. Characteristics and Patterns of Cigarette Smoking and Vaping By Past-Year Smokers Who Reported Using Electronic Nicotine Delivery System to Help Quit Smoking in the Past Year: Findings From the 2018–2019 Tobacco Use Supplement to the Current Population Survey
35. Changes in Biomarkers of Tobacco Exposure among Cigarette Smokers Transitioning to ENDS Use: The Population Assessment of Tobacco and Health Study, 2013–2015
36. Characteristics of Past 30–Day Cigar Smoking, U.S. Adolescents, 2020
37. Brief Report: Smoking-attributable Mortality in the United States
38. Estimating the Effect of Smoking on Slowdowns in Mortality Declines in Developed Countries
39. A modified new method for estimating smoking-attributable mortality in high-income countries
40. E-Cigarette-Associated Cases Reported to Poison Centers--United States, April 1, 2022-March 31, 2023
41. Flavored Tobacco Product Use Among US Youth Aged 12-17 Years, 2013-2014
42. Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users—Results from Wave 1 PATH Study
43. Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study
44. Additional file 1 of Modeling mortality risk effects of cigarettes and smokeless tobacco: results from the National Health Interview Survey Linked Mortality File Data
45. Estimation of Cigarette Smoking–Attributable Morbidity in the United States
46. Urinary Cotinine and Cotinine + Trans-3′-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013–2014)
47. Mortality and Economic Costs From Regular Cigar Use in the United States, 2010
48. Menthol Cigarette Use and Stroke Risk Among US Smokers: A Critical Reappraisal
49. ENDS Flavor Preference by Menthol Cigarette Smoking Status among US Adults, 2018–2019
50. National Estimates of ENDS Liquid Nicotine Exposures, U.S., 2013–2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.